SlideShare a Scribd company logo
applied strategic
outcomes measurement tool in opioid
dependence care
2015 AATOD National Conference – Atlanta
Dr. Richard Littlewood
March 29, 2015
Survey results: need for improved outcome
measures
2
Strongly
agree
Neutral Disagree Strongly
disagree
Agree
There is a lack of a universal
tools to measure all aspects of
care including aspects such as
recovery
29%
54%
17%
0% 0%
Stronglyagree
Agree
Neutral
Disagree
Stronglydisagree
1
Results from expert survey
Statement:
applied strategic
Survey results: potential limitations of current
measures
3
Strongly
agree
Neutral Disagree Strongly
disagree
Agree
Currently used outcome
measures (completions,
readmissions) may be too
simple to capture full benefit of
treatment
20%
14%
6%
0%
Stronglyagree
Agree
Neutral
Disagree
Stronglydisagree
2
60%
Statement:
applied strategic
Results from expert survey
• Describe outcomes
related to treatment
choices, program
participation
• Identify outcomes
capturing a person’s
health state change/
risks e.g. injecting
• Determine the
impact of crime
associated with
dependence
• Describe impact of
dependence on
economic status,
others, family,..
Progression Risk
IndividualSociety
Concept: more than one value needed to describe
outcomes (because there are many factors)
applied strategic 4
• Avoiding crime,
including OST
diversion
• Participation in a
treatment programme
• Improving health status,
avoiding misuse/
injecting drug use
• Work status
Recovery Risk
IndividualSociety
The critical elements for measurement of outcomes: how
can it work in practice?
applied strategic 5
Progression Risk
IndividualSociety
Metrics were validated with experts in a Delphi
style process: TREATMENT
applied strategic 6
Engagement in treatment is the
right way to measure treatment
outcomes in ODM
Outcome metric:
Results from consensus process:
Engagement with treatment
Strongly
agree
Neutral Disagree Strongly
disagree
Agree
32%
51%
15%
2% 0%
Stronglyagree
Agree
Neutral
Disagree
Stronglydisagree
Source: Alho Maremmani Littlewood 2014
applied strategic 7
Avoiding on-top use of opioids is
the right way to measure
outcomes in ODM
Outcome metric:
Strongly
agree
Neutral Disagree Strongly
disagree
Agree
Results from consensus process:
On-top use
40%
53%
4% 2% 0%
Stronglyagree
Agree
Neutral
Disagree
Stronglydisagree
Source: Alho Maremmani Littlewood 2014
Metrics were validated with experts in a Delphi
style process: HEALTH/ RISK
applied strategic 8
Potential to work at appropriate
skill level is the right way to
measure outcomes in ODM
Outcome metric:
Results from consensus process:
Employment
Strongly
agree
Neutral Disagree Strongly
disagree
Agree
40%
53%
7%
0% 0%
Stronglyagree
Agree
Neutral
Disagree
Stronglydisagree
Source: Alho Maremmani Littlewood 2014
Metrics were validated with experts in a Delphi
style process: WORK
Metrics were validated with experts in a Delphi
style process: CRIME
applied strategic 9
Reduction in criminal activity is the
right way to measure treatment
outcomes in ODM
Outcome metric:
Strongly
agree
Neutral Disagree Strongly
disagree
Agree
Results from consensus process:
Criminal activity
66%
32%
2% 0% 0%
Stronglyagree
Agree
Neutral
Disagree
Stronglydisagree
Source: Alho Maremmani Littlewood 2014
• Am I avoiding
crime including
diversion of
treatment
• Am I engaged with a
treatment program?
• Is my health getting
better (and am I
avoiding risks like
injecting, use on top?)
• Am I working?
Recovery Risk
IndividualSociety
An outcomes tool for real life..
applied strategic 10
Progression Risk
IndividualSociety

More Related Content

What's hot

Quantum Health Case Study
Quantum Health Case StudyQuantum Health Case Study
Quantum Health Case Study
Mark Gall
 
Implementing a sustainable screening project for alcohol related harm- A case...
Implementing a sustainable screening project for alcohol related harm- A case...Implementing a sustainable screening project for alcohol related harm- A case...
Implementing a sustainable screening project for alcohol related harm- A case...
Health Innovation Wessex
 
Twsg brochure 2015
Twsg brochure 2015Twsg brochure 2015
Twsg brochure 2015
Robert L. Wambolt, MBA
 
Institute of Clinical Research
Institute of Clinical ResearchInstitute of Clinical Research
Institute of Clinical Research
The Avoca Group
 
Opportunities & Challenges: A Home Health and Hospice Executive Survey
Opportunities & Challenges: A Home Health and Hospice Executive SurveyOpportunities & Challenges: A Home Health and Hospice Executive Survey
Opportunities & Challenges: A Home Health and Hospice Executive Survey
McKesson Corporation
 
Take Control of Your Corporate Risk Burden
Take Control of Your Corporate Risk BurdenTake Control of Your Corporate Risk Burden
Take Control of Your Corporate Risk BurdenMaureen Arndt, CISR, CC
 
Preliminary results from a survey on the use of metrics and evaluation strate...
Preliminary results from a survey on the use of metrics and evaluation strate...Preliminary results from a survey on the use of metrics and evaluation strate...
Preliminary results from a survey on the use of metrics and evaluation strate...
jehill3
 
Improving clinical services: no magic bullet... some things work better than ...
Improving clinical services: no magic bullet... some things work better than ...Improving clinical services: no magic bullet... some things work better than ...
Improving clinical services: no magic bullet... some things work better than ...
NIHR CLAHRC West Midlands
 
AI & The Patient Experience
AI & The Patient ExperienceAI & The Patient Experience
AI & The Patient Experience
Dr Avnesh Ratnanesan (Avi)
 
How to Define Effective and Efficient Real World Trials
How to Define Effective and Efficient Real World TrialsHow to Define Effective and Efficient Real World Trials
How to Define Effective and Efficient Real World Trials
Todd Berner MD
 
NHS North Derbyshire CCG- Collaborative complaints peer reviews- PEN 2015
NHS North Derbyshire CCG- Collaborative complaints peer reviews- PEN 2015NHS North Derbyshire CCG- Collaborative complaints peer reviews- PEN 2015
NHS North Derbyshire CCG- Collaborative complaints peer reviews- PEN 2015
RuthEvansPEN
 
Improving efficiencies in medication reconciliation: The McGill Story
Improving efficiencies in medication reconciliation: The McGill StoryImproving efficiencies in medication reconciliation: The McGill Story
Improving efficiencies in medication reconciliation: The McGill StoryCanadian Patient Safety Institute
 
Spotlight Webinar: GRADE
Spotlight Webinar: GRADESpotlight Webinar: GRADE
Transforming the Patient Experience HISA EHealth NSW
Transforming the Patient Experience  HISA EHealth NSWTransforming the Patient Experience  HISA EHealth NSW
Transforming the Patient Experience HISA EHealth NSW
Dr Avnesh Ratnanesan (Avi)
 
Scaling Mobile Community-Based Information Systems
Scaling Mobile Community-Based Information SystemsScaling Mobile Community-Based Information Systems
Scaling Mobile Community-Based Information Systems
MEASURE Evaluation
 
Leading health plan ignites wellness program engagement
Leading health plan ignites wellness program engagement Leading health plan ignites wellness program engagement
Leading health plan ignites wellness program engagement
HealthFitness
 
Maximizing Electronic Health Record Use in Physician Practices to Minimize Risk
Maximizing Electronic Health Record Use in Physician Practices to Minimize RiskMaximizing Electronic Health Record Use in Physician Practices to Minimize Risk
Maximizing Electronic Health Record Use in Physician Practices to Minimize Risk
Sedgwick
 
Building A Global Pharmaceutical Traceability Foundation
Building A Global Pharmaceutical Traceability FoundationBuilding A Global Pharmaceutical Traceability Foundation
Building A Global Pharmaceutical Traceability Foundation
SupplyScape
 
CISummit 2013: Pete DeWarn, Brigham Hyde, Mark Degatano, Breakthrough KOLs Pa...
CISummit 2013: Pete DeWarn, Brigham Hyde, Mark Degatano, Breakthrough KOLs Pa...CISummit 2013: Pete DeWarn, Brigham Hyde, Mark Degatano, Breakthrough KOLs Pa...
CISummit 2013: Pete DeWarn, Brigham Hyde, Mark Degatano, Breakthrough KOLs Pa...Steven Wardell
 
TransCelerate Overview - Interpretation of Pharmacovigilance Regulations Init...
TransCelerate Overview - Interpretation of Pharmacovigilance Regulations Init...TransCelerate Overview - Interpretation of Pharmacovigilance Regulations Init...
TransCelerate Overview - Interpretation of Pharmacovigilance Regulations Init...
TransCelerate
 

What's hot (20)

Quantum Health Case Study
Quantum Health Case StudyQuantum Health Case Study
Quantum Health Case Study
 
Implementing a sustainable screening project for alcohol related harm- A case...
Implementing a sustainable screening project for alcohol related harm- A case...Implementing a sustainable screening project for alcohol related harm- A case...
Implementing a sustainable screening project for alcohol related harm- A case...
 
Twsg brochure 2015
Twsg brochure 2015Twsg brochure 2015
Twsg brochure 2015
 
Institute of Clinical Research
Institute of Clinical ResearchInstitute of Clinical Research
Institute of Clinical Research
 
Opportunities & Challenges: A Home Health and Hospice Executive Survey
Opportunities & Challenges: A Home Health and Hospice Executive SurveyOpportunities & Challenges: A Home Health and Hospice Executive Survey
Opportunities & Challenges: A Home Health and Hospice Executive Survey
 
Take Control of Your Corporate Risk Burden
Take Control of Your Corporate Risk BurdenTake Control of Your Corporate Risk Burden
Take Control of Your Corporate Risk Burden
 
Preliminary results from a survey on the use of metrics and evaluation strate...
Preliminary results from a survey on the use of metrics and evaluation strate...Preliminary results from a survey on the use of metrics and evaluation strate...
Preliminary results from a survey on the use of metrics and evaluation strate...
 
Improving clinical services: no magic bullet... some things work better than ...
Improving clinical services: no magic bullet... some things work better than ...Improving clinical services: no magic bullet... some things work better than ...
Improving clinical services: no magic bullet... some things work better than ...
 
AI & The Patient Experience
AI & The Patient ExperienceAI & The Patient Experience
AI & The Patient Experience
 
How to Define Effective and Efficient Real World Trials
How to Define Effective and Efficient Real World TrialsHow to Define Effective and Efficient Real World Trials
How to Define Effective and Efficient Real World Trials
 
NHS North Derbyshire CCG- Collaborative complaints peer reviews- PEN 2015
NHS North Derbyshire CCG- Collaborative complaints peer reviews- PEN 2015NHS North Derbyshire CCG- Collaborative complaints peer reviews- PEN 2015
NHS North Derbyshire CCG- Collaborative complaints peer reviews- PEN 2015
 
Improving efficiencies in medication reconciliation: The McGill Story
Improving efficiencies in medication reconciliation: The McGill StoryImproving efficiencies in medication reconciliation: The McGill Story
Improving efficiencies in medication reconciliation: The McGill Story
 
Spotlight Webinar: GRADE
Spotlight Webinar: GRADESpotlight Webinar: GRADE
Spotlight Webinar: GRADE
 
Transforming the Patient Experience HISA EHealth NSW
Transforming the Patient Experience  HISA EHealth NSWTransforming the Patient Experience  HISA EHealth NSW
Transforming the Patient Experience HISA EHealth NSW
 
Scaling Mobile Community-Based Information Systems
Scaling Mobile Community-Based Information SystemsScaling Mobile Community-Based Information Systems
Scaling Mobile Community-Based Information Systems
 
Leading health plan ignites wellness program engagement
Leading health plan ignites wellness program engagement Leading health plan ignites wellness program engagement
Leading health plan ignites wellness program engagement
 
Maximizing Electronic Health Record Use in Physician Practices to Minimize Risk
Maximizing Electronic Health Record Use in Physician Practices to Minimize RiskMaximizing Electronic Health Record Use in Physician Practices to Minimize Risk
Maximizing Electronic Health Record Use in Physician Practices to Minimize Risk
 
Building A Global Pharmaceutical Traceability Foundation
Building A Global Pharmaceutical Traceability FoundationBuilding A Global Pharmaceutical Traceability Foundation
Building A Global Pharmaceutical Traceability Foundation
 
CISummit 2013: Pete DeWarn, Brigham Hyde, Mark Degatano, Breakthrough KOLs Pa...
CISummit 2013: Pete DeWarn, Brigham Hyde, Mark Degatano, Breakthrough KOLs Pa...CISummit 2013: Pete DeWarn, Brigham Hyde, Mark Degatano, Breakthrough KOLs Pa...
CISummit 2013: Pete DeWarn, Brigham Hyde, Mark Degatano, Breakthrough KOLs Pa...
 
TransCelerate Overview - Interpretation of Pharmacovigilance Regulations Init...
TransCelerate Overview - Interpretation of Pharmacovigilance Regulations Init...TransCelerate Overview - Interpretation of Pharmacovigilance Regulations Init...
TransCelerate Overview - Interpretation of Pharmacovigilance Regulations Init...
 

Viewers also liked

applied margin presentation leiden 2016 v2.0
applied margin presentation leiden 2016 v2.0applied margin presentation leiden 2016 v2.0
applied margin presentation leiden 2016 v2.0
Richard Littlewood
 
Housing for people with opioid use disorder
Housing for people with opioid use disorderHousing for people with opioid use disorder
Housing for people with opioid use disorder
Richard Littlewood
 
Big data analytics to step change in pathology services
Big data analytics to step change in pathology servicesBig data analytics to step change in pathology services
Big data analytics to step change in pathology services
Richard Littlewood
 
applied strategic biosimilars success
applied strategic biosimilars successapplied strategic biosimilars success
applied strategic biosimilars success
Richard Littlewood
 
applied strategic biosimilars success
applied strategic biosimilars successapplied strategic biosimilars success
applied strategic biosimilars success
Richard Littlewood
 
applied strategic 10 years vision for biosimilars
applied strategic 10 years vision for biosimilarsapplied strategic 10 years vision for biosimilars
applied strategic 10 years vision for biosimilars
Richard Littlewood
 

Viewers also liked (6)

applied margin presentation leiden 2016 v2.0
applied margin presentation leiden 2016 v2.0applied margin presentation leiden 2016 v2.0
applied margin presentation leiden 2016 v2.0
 
Housing for people with opioid use disorder
Housing for people with opioid use disorderHousing for people with opioid use disorder
Housing for people with opioid use disorder
 
Big data analytics to step change in pathology services
Big data analytics to step change in pathology servicesBig data analytics to step change in pathology services
Big data analytics to step change in pathology services
 
applied strategic biosimilars success
applied strategic biosimilars successapplied strategic biosimilars success
applied strategic biosimilars success
 
applied strategic biosimilars success
applied strategic biosimilars successapplied strategic biosimilars success
applied strategic biosimilars success
 
applied strategic 10 years vision for biosimilars
applied strategic 10 years vision for biosimilarsapplied strategic 10 years vision for biosimilars
applied strategic 10 years vision for biosimilars
 

Similar to Applied aatod presentation highlights

FINAL-MB-NAVEXGlobal-AHASignatureSeries-BenchmarkingYourHealthcarePolicyManag...
FINAL-MB-NAVEXGlobal-AHASignatureSeries-BenchmarkingYourHealthcarePolicyManag...FINAL-MB-NAVEXGlobal-AHASignatureSeries-BenchmarkingYourHealthcarePolicyManag...
FINAL-MB-NAVEXGlobal-AHASignatureSeries-BenchmarkingYourHealthcarePolicyManag...Mary Bennett
 
State of the Independent Practice: What it Means For You
State of the Independent Practice: What it Means For YouState of the Independent Practice: What it Means For You
State of the Independent Practice: What it Means For You
Kareo
 
2013 Avoca Industry Survey Executive Summary
2013 Avoca Industry Survey Executive Summary2013 Avoca Industry Survey Executive Summary
2013 Avoca Industry Survey Executive Summary
The Avoca Group
 
Avoca 2014 DIA Presentation
Avoca 2014 DIA PresentationAvoca 2014 DIA Presentation
Avoca 2014 DIA Presentation
The Avoca Group
 
Software Advice IndustryView: Volunteer Impact Report
Software Advice IndustryView: Volunteer Impact ReportSoftware Advice IndustryView: Volunteer Impact Report
Software Advice IndustryView: Volunteer Impact Report
Software Advice
 
Success Factors and Failure Points in Metabolic Product Launches Report Summary
Success Factors and Failure Points in Metabolic Product Launches Report SummarySuccess Factors and Failure Points in Metabolic Product Launches Report Summary
Success Factors and Failure Points in Metabolic Product Launches Report Summary
Best Practices
 
2015 Strategic Benefits―Health Care
2015 Strategic Benefits―Health Care2015 Strategic Benefits―Health Care
2015 Strategic Benefits―Health Care
shrm
 
AMA Digital Health Study
AMA Digital Health Study AMA Digital Health Study
AMA Digital Health Study
Brian Ahier
 
Success Factors and Failure Points in Biopharmaceutical Product Launches: An ...
Success Factors and Failure Points in Biopharmaceutical Product Launches: An ...Success Factors and Failure Points in Biopharmaceutical Product Launches: An ...
Success Factors and Failure Points in Biopharmaceutical Product Launches: An ...
Best Practices
 
2015 Strategic Benefits—Wellness Initiatives
2015 Strategic Benefits—Wellness Initiatives2015 Strategic Benefits—Wellness Initiatives
2015 Strategic Benefits—Wellness Initiatives
shrm
 
The 2013 Avoca Report
The 2013 Avoca Report The 2013 Avoca Report
The 2013 Avoca Report
The Avoca Group
 
Dissemination Strategies_Kristina Gryboski
Dissemination Strategies_Kristina GryboskiDissemination Strategies_Kristina Gryboski
Dissemination Strategies_Kristina GryboskiCORE Group
 
Managing Risk in Outsourced Clinical Trials
Managing Risk in Outsourced Clinical TrialsManaging Risk in Outsourced Clinical Trials
Managing Risk in Outsourced Clinical Trials
The Avoca Group
 
Principles of surgical audit
Principles of surgical auditPrinciples of surgical audit
Principles of surgical audit
Meeran Earfan
 
Marketing in the Age of Person-centric Healthcare
Marketing in the Age of Person-centric HealthcareMarketing in the Age of Person-centric Healthcare
Marketing in the Age of Person-centric Healthcare
Ogilvy Consulting
 
Optimize the Role of Medical Affairs in Health Economics & Outcomes Research ...
Optimize the Role of Medical Affairs in Health Economics & Outcomes Research ...Optimize the Role of Medical Affairs in Health Economics & Outcomes Research ...
Optimize the Role of Medical Affairs in Health Economics & Outcomes Research ...
Best Practices
 

Similar to Applied aatod presentation highlights (20)

FINAL-MB-NAVEXGlobal-AHASignatureSeries-BenchmarkingYourHealthcarePolicyManag...
FINAL-MB-NAVEXGlobal-AHASignatureSeries-BenchmarkingYourHealthcarePolicyManag...FINAL-MB-NAVEXGlobal-AHASignatureSeries-BenchmarkingYourHealthcarePolicyManag...
FINAL-MB-NAVEXGlobal-AHASignatureSeries-BenchmarkingYourHealthcarePolicyManag...
 
State of the Independent Practice: What it Means For You
State of the Independent Practice: What it Means For YouState of the Independent Practice: What it Means For You
State of the Independent Practice: What it Means For You
 
2013 Avoca Industry Survey Executive Summary
2013 Avoca Industry Survey Executive Summary2013 Avoca Industry Survey Executive Summary
2013 Avoca Industry Survey Executive Summary
 
Avoca 2014 DIA Presentation
Avoca 2014 DIA PresentationAvoca 2014 DIA Presentation
Avoca 2014 DIA Presentation
 
Software Advice IndustryView: Volunteer Impact Report
Software Advice IndustryView: Volunteer Impact ReportSoftware Advice IndustryView: Volunteer Impact Report
Software Advice IndustryView: Volunteer Impact Report
 
Success Factors and Failure Points in Metabolic Product Launches Report Summary
Success Factors and Failure Points in Metabolic Product Launches Report SummarySuccess Factors and Failure Points in Metabolic Product Launches Report Summary
Success Factors and Failure Points in Metabolic Product Launches Report Summary
 
Laboratory Medicine Best Practices (LMBP)
Laboratory Medicine Best Practices (LMBP)Laboratory Medicine Best Practices (LMBP)
Laboratory Medicine Best Practices (LMBP)
 
2015 Strategic Benefits―Health Care
2015 Strategic Benefits―Health Care2015 Strategic Benefits―Health Care
2015 Strategic Benefits―Health Care
 
Survey Report
Survey ReportSurvey Report
Survey Report
 
AMA Digital Health Study
AMA Digital Health Study AMA Digital Health Study
AMA Digital Health Study
 
Success Factors and Failure Points in Biopharmaceutical Product Launches: An ...
Success Factors and Failure Points in Biopharmaceutical Product Launches: An ...Success Factors and Failure Points in Biopharmaceutical Product Launches: An ...
Success Factors and Failure Points in Biopharmaceutical Product Launches: An ...
 
HC360-OurSystem
HC360-OurSystemHC360-OurSystem
HC360-OurSystem
 
2015 Strategic Benefits—Wellness Initiatives
2015 Strategic Benefits—Wellness Initiatives2015 Strategic Benefits—Wellness Initiatives
2015 Strategic Benefits—Wellness Initiatives
 
The 2013 Avoca Report
The 2013 Avoca Report The 2013 Avoca Report
The 2013 Avoca Report
 
Handout
HandoutHandout
Handout
 
Dissemination Strategies_Kristina Gryboski
Dissemination Strategies_Kristina GryboskiDissemination Strategies_Kristina Gryboski
Dissemination Strategies_Kristina Gryboski
 
Managing Risk in Outsourced Clinical Trials
Managing Risk in Outsourced Clinical TrialsManaging Risk in Outsourced Clinical Trials
Managing Risk in Outsourced Clinical Trials
 
Principles of surgical audit
Principles of surgical auditPrinciples of surgical audit
Principles of surgical audit
 
Marketing in the Age of Person-centric Healthcare
Marketing in the Age of Person-centric HealthcareMarketing in the Age of Person-centric Healthcare
Marketing in the Age of Person-centric Healthcare
 
Optimize the Role of Medical Affairs in Health Economics & Outcomes Research ...
Optimize the Role of Medical Affairs in Health Economics & Outcomes Research ...Optimize the Role of Medical Affairs in Health Economics & Outcomes Research ...
Optimize the Role of Medical Affairs in Health Economics & Outcomes Research ...
 

Recently uploaded

Immunity to Veterinary parasitic infections power point presentation
Immunity to Veterinary parasitic infections power point presentationImmunity to Veterinary parasitic infections power point presentation
Immunity to Veterinary parasitic infections power point presentation
BeshedaWedajo
 
Preventing Pickleball Injuries & Treatment
Preventing Pickleball Injuries & TreatmentPreventing Pickleball Injuries & Treatment
Preventing Pickleball Injuries & Treatment
LAB Sports Therapy
 
Performance Standards for Antimicrobial Susceptibility Testing
Performance Standards for Antimicrobial Susceptibility TestingPerformance Standards for Antimicrobial Susceptibility Testing
Performance Standards for Antimicrobial Susceptibility Testing
Nguyễn Thị Vân Anh
 
GENERAL PHARMACOLOGY - INTRODUCTION DENTAL.ppt
GENERAL PHARMACOLOGY - INTRODUCTION DENTAL.pptGENERAL PHARMACOLOGY - INTRODUCTION DENTAL.ppt
GENERAL PHARMACOLOGY - INTRODUCTION DENTAL.ppt
Mangaiarkkarasi
 
Antibiotic Stewardship by Anushri Srivastava.pptx
Antibiotic Stewardship by Anushri Srivastava.pptxAntibiotic Stewardship by Anushri Srivastava.pptx
Antibiotic Stewardship by Anushri Srivastava.pptx
AnushriSrivastav
 
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptx
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptx
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptx
R3 Stem Cell
 
Secret Tantric VIP Erotic Massage London
Secret Tantric VIP Erotic Massage LondonSecret Tantric VIP Erotic Massage London
Secret Tantric VIP Erotic Massage London
Secret Tantric - VIP Erotic Massage London
 
GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
ranishasharma67
 
Myopia Management & Control Strategies.pptx
Myopia Management & Control Strategies.pptxMyopia Management & Control Strategies.pptx
Myopia Management & Control Strategies.pptx
RitonDeb1
 
Navigating the Health Insurance Market_ Understanding Trends and Options.pdf
Navigating the Health Insurance Market_ Understanding Trends and Options.pdfNavigating the Health Insurance Market_ Understanding Trends and Options.pdf
Navigating the Health Insurance Market_ Understanding Trends and Options.pdf
Enterprise Wired
 
Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdfDemystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
SasikiranMarri
 
Telehealth Psychology Building Trust with Clients.pptx
Telehealth Psychology Building Trust with Clients.pptxTelehealth Psychology Building Trust with Clients.pptx
Telehealth Psychology Building Trust with Clients.pptx
The Harvest Clinic
 
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...
Kumar Satyam
 
Deepfake Detection_Using Machine Learning .pptx
Deepfake Detection_Using Machine Learning .pptxDeepfake Detection_Using Machine Learning .pptx
Deepfake Detection_Using Machine Learning .pptx
mahalsuraj389
 
Introduction to Forensic Pathology course
Introduction to Forensic Pathology courseIntroduction to Forensic Pathology course
Introduction to Forensic Pathology course
fprxsqvnz5
 
ABDOMINAL COMPARTMENT SYSNDROME
ABDOMINAL COMPARTMENT SYSNDROMEABDOMINAL COMPARTMENT SYSNDROME
ABDOMINAL COMPARTMENT SYSNDROME
Rommel Luis III Israel
 
Navigating Healthcare with Telemedicine
Navigating Healthcare with  TelemedicineNavigating Healthcare with  Telemedicine
Navigating Healthcare with Telemedicine
Iris Thiele Isip-Tan
 
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdf
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfCHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdf
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdf
Sachin Sharma
 
A Community health , health for prisoners
A Community health  , health for prisonersA Community health  , health for prisoners
A Community health , health for prisoners
Ahmed Elmi
 
HEAT WAVE presented by priya bhojwani..pptx
HEAT WAVE presented by priya bhojwani..pptxHEAT WAVE presented by priya bhojwani..pptx
HEAT WAVE presented by priya bhojwani..pptx
priyabhojwani1200
 

Recently uploaded (20)

Immunity to Veterinary parasitic infections power point presentation
Immunity to Veterinary parasitic infections power point presentationImmunity to Veterinary parasitic infections power point presentation
Immunity to Veterinary parasitic infections power point presentation
 
Preventing Pickleball Injuries & Treatment
Preventing Pickleball Injuries & TreatmentPreventing Pickleball Injuries & Treatment
Preventing Pickleball Injuries & Treatment
 
Performance Standards for Antimicrobial Susceptibility Testing
Performance Standards for Antimicrobial Susceptibility TestingPerformance Standards for Antimicrobial Susceptibility Testing
Performance Standards for Antimicrobial Susceptibility Testing
 
GENERAL PHARMACOLOGY - INTRODUCTION DENTAL.ppt
GENERAL PHARMACOLOGY - INTRODUCTION DENTAL.pptGENERAL PHARMACOLOGY - INTRODUCTION DENTAL.ppt
GENERAL PHARMACOLOGY - INTRODUCTION DENTAL.ppt
 
Antibiotic Stewardship by Anushri Srivastava.pptx
Antibiotic Stewardship by Anushri Srivastava.pptxAntibiotic Stewardship by Anushri Srivastava.pptx
Antibiotic Stewardship by Anushri Srivastava.pptx
 
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptx
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptx
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptx
 
Secret Tantric VIP Erotic Massage London
Secret Tantric VIP Erotic Massage LondonSecret Tantric VIP Erotic Massage London
Secret Tantric VIP Erotic Massage London
 
GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
 
Myopia Management & Control Strategies.pptx
Myopia Management & Control Strategies.pptxMyopia Management & Control Strategies.pptx
Myopia Management & Control Strategies.pptx
 
Navigating the Health Insurance Market_ Understanding Trends and Options.pdf
Navigating the Health Insurance Market_ Understanding Trends and Options.pdfNavigating the Health Insurance Market_ Understanding Trends and Options.pdf
Navigating the Health Insurance Market_ Understanding Trends and Options.pdf
 
Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdfDemystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
Demystifying-Gene-Editing-The-Promise-and-Peril-of-CRISPR.pdf
 
Telehealth Psychology Building Trust with Clients.pptx
Telehealth Psychology Building Trust with Clients.pptxTelehealth Psychology Building Trust with Clients.pptx
Telehealth Psychology Building Trust with Clients.pptx
 
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...
 
Deepfake Detection_Using Machine Learning .pptx
Deepfake Detection_Using Machine Learning .pptxDeepfake Detection_Using Machine Learning .pptx
Deepfake Detection_Using Machine Learning .pptx
 
Introduction to Forensic Pathology course
Introduction to Forensic Pathology courseIntroduction to Forensic Pathology course
Introduction to Forensic Pathology course
 
ABDOMINAL COMPARTMENT SYSNDROME
ABDOMINAL COMPARTMENT SYSNDROMEABDOMINAL COMPARTMENT SYSNDROME
ABDOMINAL COMPARTMENT SYSNDROME
 
Navigating Healthcare with Telemedicine
Navigating Healthcare with  TelemedicineNavigating Healthcare with  Telemedicine
Navigating Healthcare with Telemedicine
 
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdf
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfCHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdf
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdf
 
A Community health , health for prisoners
A Community health  , health for prisonersA Community health  , health for prisoners
A Community health , health for prisoners
 
HEAT WAVE presented by priya bhojwani..pptx
HEAT WAVE presented by priya bhojwani..pptxHEAT WAVE presented by priya bhojwani..pptx
HEAT WAVE presented by priya bhojwani..pptx
 

Applied aatod presentation highlights

  • 1. applied strategic outcomes measurement tool in opioid dependence care 2015 AATOD National Conference – Atlanta Dr. Richard Littlewood March 29, 2015
  • 2. Survey results: need for improved outcome measures 2 Strongly agree Neutral Disagree Strongly disagree Agree There is a lack of a universal tools to measure all aspects of care including aspects such as recovery 29% 54% 17% 0% 0% Stronglyagree Agree Neutral Disagree Stronglydisagree 1 Results from expert survey Statement: applied strategic
  • 3. Survey results: potential limitations of current measures 3 Strongly agree Neutral Disagree Strongly disagree Agree Currently used outcome measures (completions, readmissions) may be too simple to capture full benefit of treatment 20% 14% 6% 0% Stronglyagree Agree Neutral Disagree Stronglydisagree 2 60% Statement: applied strategic Results from expert survey
  • 4. • Describe outcomes related to treatment choices, program participation • Identify outcomes capturing a person’s health state change/ risks e.g. injecting • Determine the impact of crime associated with dependence • Describe impact of dependence on economic status, others, family,.. Progression Risk IndividualSociety Concept: more than one value needed to describe outcomes (because there are many factors) applied strategic 4
  • 5. • Avoiding crime, including OST diversion • Participation in a treatment programme • Improving health status, avoiding misuse/ injecting drug use • Work status Recovery Risk IndividualSociety The critical elements for measurement of outcomes: how can it work in practice? applied strategic 5 Progression Risk IndividualSociety
  • 6. Metrics were validated with experts in a Delphi style process: TREATMENT applied strategic 6 Engagement in treatment is the right way to measure treatment outcomes in ODM Outcome metric: Results from consensus process: Engagement with treatment Strongly agree Neutral Disagree Strongly disagree Agree 32% 51% 15% 2% 0% Stronglyagree Agree Neutral Disagree Stronglydisagree Source: Alho Maremmani Littlewood 2014
  • 7. applied strategic 7 Avoiding on-top use of opioids is the right way to measure outcomes in ODM Outcome metric: Strongly agree Neutral Disagree Strongly disagree Agree Results from consensus process: On-top use 40% 53% 4% 2% 0% Stronglyagree Agree Neutral Disagree Stronglydisagree Source: Alho Maremmani Littlewood 2014 Metrics were validated with experts in a Delphi style process: HEALTH/ RISK
  • 8. applied strategic 8 Potential to work at appropriate skill level is the right way to measure outcomes in ODM Outcome metric: Results from consensus process: Employment Strongly agree Neutral Disagree Strongly disagree Agree 40% 53% 7% 0% 0% Stronglyagree Agree Neutral Disagree Stronglydisagree Source: Alho Maremmani Littlewood 2014 Metrics were validated with experts in a Delphi style process: WORK
  • 9. Metrics were validated with experts in a Delphi style process: CRIME applied strategic 9 Reduction in criminal activity is the right way to measure treatment outcomes in ODM Outcome metric: Strongly agree Neutral Disagree Strongly disagree Agree Results from consensus process: Criminal activity 66% 32% 2% 0% 0% Stronglyagree Agree Neutral Disagree Stronglydisagree Source: Alho Maremmani Littlewood 2014
  • 10. • Am I avoiding crime including diversion of treatment • Am I engaged with a treatment program? • Is my health getting better (and am I avoiding risks like injecting, use on top?) • Am I working? Recovery Risk IndividualSociety An outcomes tool for real life.. applied strategic 10 Progression Risk IndividualSociety